TrianglePUBLICATIONS · 19846851
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- N Engl J Med
- Publication date
- 2009 Oct 22
- First author
- Perilongo G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Perilongo G
- type
- Author
- name
- Maibach R
- type
- Author
- name
- Shafford E
- type
- Author
- name
- Brugieres L
- type
- Author
- name
- Brock P
- type
- Author
- name
- Morland B
- type
- Author
- name
- de Camargo B
- type
- Author
- name
- Zsiros J
- type
- Author
- name
- Roebuck D
- type
- Author
- name
- Zimmermann A
- type
- Author
- name
- Aronson D
- type
- Author
- name
- Childs M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Perilongo G
- type
- Author
- name
- Maibach R
- type
- Author
- name
- Shafford E
- type
- Author
- name
- Brugieres L
- type
- Author
- name
- Brock P
- type
- Author
- name
- Morland B
- type
- Author
- name
- de Camargo B
- type
- Author
- name
- Zsiros J
- type
- Author
- name
- Roebuck D
- type
- Author
- name
- Zimmermann A
- type
- Author
- name
- Aronson D
- type
- Author
- name
- Childs M
- type
- Author
- bibliography ids
- nci-bib-f143214a00489a3ca91b4e55
- book metadata
- content sha256
- e2275108bb1be61918cabd09b88c3162ab1c2ccda89926a349a04549d2362080
- document type
- citation
- dois
- 10.1056/NEJMoa0810613
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19846851
- immutable id
- pubmed:19846851@e2275108bb1be61918cabd09b88c3162ab1c2ccda89926a349a04549d2362080
- journal
- abbreviation
- N Engl J Med
- issn electronic
- 1533-4406
- issn print
- 0028-4793
- issue
- 17
- name
- The New England journal of medicine
- nlm unique id
- 0255562
- pages
- 1662-70
- volume
- 361
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19846851
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 8f8718184215fe74617e6278fbbc990c06acd0ce6445724dddb4e94bfef2b818
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Oct 22
- precision
- day
- year
- 2009
- publication types
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Preserved source evidence · Not medical advice